Adults with established cardiovascular disease and overweight or obesity without diabetes now have an FDA-approved indication for Wegovy (semaglutide 2.4 mg) to reduce the risk of cardiovascular death, heart attack, and stroke, based on the SELECT trial results
Exercise: Begin light activities like walking or yoga to build consistency
68.Hansen H.H., Pors S., Andersen M.W., Vyberg M., Nhr-Meldgaard J., Nielsen M.H., et al
It functions by mimicking the natural GLP-1 hormone, which plays a pivotal role in metabolic regulation within the body
Other Benefits of Tirzepatide and Semaglutide Your goal may be weight loss, but these medications may significantly boost your health in other ways, too: Heart health: Theres significant evidence that semaglutide reduces the risk of heart attack and stroke, plus promising indications that tirzepatide may similarly boost heart health as well